
Opinion|Videos|April 7, 2025
A Case Study of Elevated Lp(a) Levels and Increased ASCVD Risk
Author(s)Nihar Desai, MD, MPH
Nathan Wong, PhD
Nathan Wong, PhD
Experts discuss an example illustrating the association between lipoprotein(a) (Lp[a]) levels and atherosclerotic cardiovascular disease (ASCVD) risk and explore how this example can inform our understanding of Lp(a) and ASCVD risk on a population level.
Advertisement
Video content above is prompted by the following:
- Dr Wong, can you offer an example illustrating the association between Lp(a) levels and ASCVD risk?
- How might Dr Wong’s example inform how we think about Lp(a) and ASCVD risk on a population level?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
3
Supporting Pharmacy Residents in Completing Research Projects at UC Davis: Jeremiah J. Duby, PharmD, BCPS, BCCCP
4
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
5